CE认证
皮肤填充剂
Revanesse Shape+ is a colourless, odourless and transparent aqueous gel of synthetic origin from Prollenium Medical Technologies in Aurora, Canada, indicated for treating lipoatrophy and medium to deep facial rhytides. Its injection target is the middle part of the dermis layer, and the implant lasts 6 to 12 months on average. The gel is made of 25 mg/mL of hyaluronic acid, cross-linked with BDDE, and 0.3% lidocaine in phosphate-buffered saline, for professional use only. Every box holds two 1.2 mL syringes with up to two sterilised 27G needles.
主要优势： Revanesse Shape™+
- Cross-linked hyaluronic acid 25 mg/mL with 0.3% lidocaine for injection comfort
- Indicated for medium to deep facial rhytides and for lipoatrophy
- Placed in the middle part of the dermis layer
- Implantation life averages 6 to 12 months
- Supplied as two 1.2 mL pre-filled syringes with up to two sterilised 27G needles
- BDDE cross-linked in phosphate-buffered saline
- CE marked 0653 for the syringe, with CE 0123 needles
适应症与专业用途
主要适应症
- Medium to deep facial rhytides
- Lipoatrophy
专业用途
For professional use. Revanesse Shape+ should only be injected by or under the direct supervision of qualified physicians trained in the proper injection technique for filling facial wrinkles, and is not for retail sale or self-administration. It is placed in the middle part of the dermis layer. The area must be thoroughly disinfected and injection performed under sterile conditions; bring the product to room temperature for 30 minutes beforehand, prime the syringe until a small drop appears at the needle tip, and inject slowly with the least pressure necessary. If the skin blanches, stop immediately and massage until normal colour returns. It must not be injected into an area already containing another filler or a permanent implant, and must not contact quaternary ammonium salts such as benzalkonium chloride. Store between 2 and 25 degrees Celsius, protected from direct sunlight and freezing.
治疗部位
- Face
适用患者
For adult patients seeking correction of medium to deep facial rhytides or of lipoatrophy, as assessed by a qualified physician. Because it contains lidocaine, it is contraindicated in patients with hypersensitivity to any amide-type local anaesthetic. Further contraindications include hypertrophic scarring, acne or other inflammatory skin disease, acute or chronic skin disease at or near the injection site, auto-immune disorders or immunotherapy, multiple severe allergies, coagulation defects or anti-coagulation therapy, sensitivity to hyaluronic acid, and unattainable expectations. It contains trace amounts of gram-positive bacterial proteins and is contraindicated in patients allergic to such material. It must not be used during pregnancy or lactation, in anyone under 18, or in conjunction with laser, intense pulsed light, chemical peeling or dermabrasion.
作用原理： Revanesse Shape™+
Shape+ is a cross-linked hyaluronic acid gel that occupies volume in the dermis where it is placed, correcting medium to deep rhytides and the volume loss of lipoatrophy. Because it is placed in the middle part of the dermis rather than superficially, how long it lasts depends on the depth and location of the injection, which is why it lasts 6 to 12 months rather than a fixed period. The 0.3% lidocaine is present for injection comfort, which makes hypersensitivity to amide-type anaesthetics an outright contraindication.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 REVANESSE 产品，来自经过严格审核的供应商，具备完整的批次可追溯性和专家支持。我们为诊所和医美专业人士提供CE认证产品、从欧盟仓库快速配送至欧盟各地，以及具有竞争力的专业价格。我们关注的是您患者的安全、满意度和效果，并提供专属售后支持，让您安心无忧。
常见问题
How does Revanesse Shape™+ differ from Revanesse Sculpt™+?
They share the same specification: 25 mg/mL cross-linked hyaluronic acid with 0.3% lidocaine, two 1.2 mL syringes with 27G needles, placed in the middle part of the dermis for medium to deep facial rhytides and lipoatrophy, lasting 6 to 12 months.
What should a practitioner do if the skin blanches during injection?
Stop the injection immediately and massage the area until the skin returns to its normal colour. Blanching can signal intravascular placement, which has been associated with embolisation, vision impairment, blindness, skin necrosis and stroke.
更多产品： Prollenium Medical Technologies
诊所替代选择
/ 最近浏览
继续浏览
Revanesse Shape+ is a colourless, odourless and transparent aqueous gel of synthetic origin from Prollenium Medical Technologies in Aurora, Canada, indicated for treating lipoatrophy and medium to deep facial rhytides. Its injection target is the middle part of the dermis layer, and the implant lasts 6 to 12 months on average. The gel is made of 25 mg/mL of hyaluronic acid, cross-linked with BDDE, and 0.3% lidocaine in phosphate-buffered saline, for professional use only. Every box holds two 1.2 mL syringes with up to two sterilised 27G needles.
主要优势： Revanesse Shape™+
- Cross-linked hyaluronic acid 25 mg/mL with 0.3% lidocaine for injection comfort
- Indicated for medium to deep facial rhytides and for lipoatrophy
- Placed in the middle part of the dermis layer
- Implantation life averages 6 to 12 months
- Supplied as two 1.2 mL pre-filled syringes with up to two sterilised 27G needles
- BDDE cross-linked in phosphate-buffered saline
- CE marked 0653 for the syringe, with CE 0123 needles
适应症与专业用途
主要适应症
- Medium to deep facial rhytides
- Lipoatrophy
专业用途
For professional use. Revanesse Shape+ should only be injected by or under the direct supervision of qualified physicians trained in the proper injection technique for filling facial wrinkles, and is not for retail sale or self-administration. It is placed in the middle part of the dermis layer. The area must be thoroughly disinfected and injection performed under sterile conditions; bring the product to room temperature for 30 minutes beforehand, prime the syringe until a small drop appears at the needle tip, and inject slowly with the least pressure necessary. If the skin blanches, stop immediately and massage until normal colour returns. It must not be injected into an area already containing another filler or a permanent implant, and must not contact quaternary ammonium salts such as benzalkonium chloride. Store between 2 and 25 degrees Celsius, protected from direct sunlight and freezing.
治疗部位
- Face
适用患者
For adult patients seeking correction of medium to deep facial rhytides or of lipoatrophy, as assessed by a qualified physician. Because it contains lidocaine, it is contraindicated in patients with hypersensitivity to any amide-type local anaesthetic. Further contraindications include hypertrophic scarring, acne or other inflammatory skin disease, acute or chronic skin disease at or near the injection site, auto-immune disorders or immunotherapy, multiple severe allergies, coagulation defects or anti-coagulation therapy, sensitivity to hyaluronic acid, and unattainable expectations. It contains trace amounts of gram-positive bacterial proteins and is contraindicated in patients allergic to such material. It must not be used during pregnancy or lactation, in anyone under 18, or in conjunction with laser, intense pulsed light, chemical peeling or dermabrasion.
作用原理： Revanesse Shape™+
Shape+ is a cross-linked hyaluronic acid gel that occupies volume in the dermis where it is placed, correcting medium to deep rhytides and the volume loss of lipoatrophy. Because it is placed in the middle part of the dermis rather than superficially, how long it lasts depends on the depth and location of the injection, which is why it lasts 6 to 12 months rather than a fixed period. The 0.3% lidocaine is present for injection comfort, which makes hypersensitivity to amide-type anaesthetics an outright contraindication.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 REVANESSE 产品，具备完整的批次可追溯性、CE认证库存、欧盟范围内快速配送以及专业的售后支持。
常见问题
How does Revanesse Shape™+ differ from Revanesse Sculpt™+?
They share the same specification: 25 mg/mL cross-linked hyaluronic acid with 0.3% lidocaine, two 1.2 mL syringes with 27G needles, placed in the middle part of the dermis for medium to deep facial rhytides and lipoatrophy, lasting 6 to 12 months.
What should a practitioner do if the skin blanches during injection?
Stop the injection immediately and massage the area until the skin returns to its normal colour. Blanching can signal intravascular placement, which has been associated with embolisation, vision impairment, blindness, skin necrosis and stroke.
更多产品： Prollenium Medical Technologies
查看制造商 →* 专业用途产品。包装可能因批次或市场而异。完整的使用说明和禁忌症请参阅随附的使用说明书。